NYSE American - Nasdaq Real Time Price USD
Actinium Pharmaceuticals, Inc. (ATNM)
1.6400
-0.0600
(-3.53%)
At close: May 23 at 4:00:00 PM EDT
1.6400
0.00
(0.00%)
After hours: May 23 at 6:08:40 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 3 | 3 |
| Avg. Estimate | -0.35 | -0.36 | -1.48 | -0.77 |
| Low Estimate | -0.46 | -0.47 | -1.64 | -1.13 |
| High Estimate | -0.3 | -0.3 | -1.2 | -0.08 |
| Year Ago EPS | -0.38 | -0.37 | -1.27 | -1.48 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -- | -- | -- | 14.75M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 38.74M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.4 | -0.37 | -0.39 | -0.28 |
| EPS Actual | -0.38 | -0.37 | -0.21 | -0.51 |
| Difference | 0.02 | -0 | 0.18 | -0.23 |
| Surprise % | 5.00% | -0.91% | 46.15% | -83.78% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.35 | -0.36 | -1.48 | -0.77 |
| 7 Days Ago | -0.09 | -0.34 | -1.15 | -0.75 |
| 30 Days Ago | -0.36 | -0.38 | -1.23 | -0.99 |
| 60 Days Ago | 0.07 | -0.41 | -0.7 | -1.01 |
| 90 Days Ago | 0.07 | -0.41 | -0.7 | -1.01 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | 2 |
| Down Last 7 Days | 1 | -- | 2 | 2 |
| Down Last 30 Days | 2 | 1 | 2 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ATNM | 7.24% | 2.03% | -16.54% | 47.97% |
| S&P 500 | 12.56% | 2.53% | 7.37% | 14.09% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/12/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/28/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/25/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/20/2025 |
Related Tickers
CTXR Citius Pharmaceuticals, Inc.
0.7030
-2.90%
ACET Adicet Bio, Inc.
0.6936
-3.49%
ABEO Abeona Therapeutics Inc.
6.42
-2.43%
KPTI Karyopharm Therapeutics Inc.
4.5900
-1.08%
PDSB PDS Biotechnology Corporation
1.5800
+0.64%
XFOR X4 Pharmaceuticals, Inc.
3.1000
-4.02%
ZURA Zura Bio Limited
1.0200
-1.92%
AGEN Agenus Inc.
3.8200
+0.79%
SNDX Syndax Pharmaceuticals, Inc.
9.85
-8.88%
AXSM Axsome Therapeutics, Inc.
105.07
+0.69%